Market news, stock analysis and investing ideas

CDT Equity Halts Twice Around a $2 Takeover Letter: How the Pauses Work

CDT was halted for pending news on Nov. 5, then paused for volatility on Nov. 6 after a $2.00-per-share takeover letter from its largest holder. The case shows how each stop works and what it does not tell traders.

CDT Trading Halt Takeover Alert

CDT Equity Inc. (NASDAQ: CDT) was halted for pending news at 7:50 p.m. ET on Nov. 5 and reopened at 9:00 a.m. ET on Nov. 6. At 9:15 a.m., Corvus Capital Ltd. filed a Schedule 13D/A with a letter from CDT's largest shareholder, Andrew Regan, saying Corvus intends to propose buying the company at $2.00 per share. The letter is not a binding offer, and the board's response is not disclosed.

Two stops, one story, and a timeline that does not line up neatly

The overnight halt ended 15 minutes before the filing appeared, and it is not clear what news the halt was waiting for. The 9:38 a.m. pause came after the filing, but a volatility pause responds to how fast the price moves, whatever the cause. The letter cannot explain the overnight halt, which ended before the filing.

How a news-pending halt and a volatility pause work

A news-pending halt is called by the exchange. Nasdaq stops trading in a stock when the company is about to release information that could move the price, so everyone receives it at the same time. Trading restarts once the news is out and traders have had time to read it, often with a short window to post quotes before trades match.

A volatility pause is automatic. Under the limit up-limit down rules, each stock has a price band around a reference price built from recent trades. If the price hits the edge of the band and stays there, trading stops for a few minutes and then reopens. A pause sets no price and passes no judgment on the news. It only slows the pace.

What CDT shares did around each stop

Thursday's close was $0.846. In after-hours trading (the session after the 4 p.m. close) that day, the shares ended at $0.964, up 13.95%.

Pre-market (trading before the 9:30 a.m. open) on Nov. 6, the shares reached $1.37 by 9:29 a.m., up 42.12% from the after-hours close and 61.94% from Thursday's close. The range ran from $0.90 to $1.61 on 5.75 million shares, about 4.09 times the 10-day average pace. It is not clear how much of the move came before the 9:15 a.m. filing.

Nasdaq paused CDT for a volatility stop from 9:38 a.m. to 9:43 a.m. ET. The regular session closed at $1.31, down 4.38% from the pre-market close and up 54.85% from Thursday's close. Volume was 20.55 million shares, 63.33 times the 10-day average, with a low of $0.981 and a high of $1.61.

In after-hours trading Friday, the shares fell 8.4% from the $1.31 close to $1.20 on 798,993 shares.

The path into the story was steep. The worst day from Oct. 8 to Nov. 5 was Oct. 14, down 46.67%. The shares then lost 24.03% on Nov. 4 to close at $1.02, and 16.9% on Nov. 5. The Nov. 5 low was $0.78.

Why the price stayed below $2.00

The letter calls $2.00 a 96.3% premium to the Nov. 4 close. Friday's close of $1.31 was below that level. Regan wrote that any deal would need due diligence, definitive documentation, a recommendation from independent directors and several approvals, and that the letter creates no legal obligation.

Regan has interests on both sides, which the letter acknowledges. He said he and entities he controls held 2,064,698 CDT shares, about 22.15% of the company, as of Oct. 23. Corvus also owns about 43% of Sarborg Limited, CDT's main asset. He was CDT's chief executive until Aug. 31 and now leads Sarborg.

Share counts add to the uncertainty. The letter uses 1,017,864 shares outstanding after a reverse split (a consolidation of shares into fewer, higher-priced ones) that CDT announced Nov. 4. Friday's volume of 20.55 million shares is far above that figure, and the trading data lists a float of 4.41 million shares.

What the letter says about the company

  • Stockholders' equity was about $103 million at June 30, according to the letter's reading of the latest quarterly report.
  • CDT holds 1,290 Sarborg shares, about 22.7% of Sarborg, acquired for about $123 million. Regan values the stake at about $161 million, using the last Sarborg investment price.
  • Regan argues the shares trade at a fraction of those assets and that shareholders have no route to realize the Sarborg value.
  • Corvus intends to make the $2.00 proposal if the board does not put forward its own plan, such as a license deal or development of its pharmaceutical assets.

What to watch next

  • The board's response, including whether it discloses the letter, which Regan asked it to do.
  • Whether Corvus makes a formal proposal and whether the independent directors take it up.
  • Terms of the reverse split announced Nov. 4.

Bottom line

The halt gave the market a pause before news arrived, and the volatility pause slowed a fast move. Neither says anything about the merit of the $2.00 idea. So far there is a non-binding letter from a holder with interests in both CDT and Sarborg, and a stock that closed Friday at $1.31.


This article was processed by WSN Finance AI Analysis and prepared by WSN Editors based on financial analysis.

This article is for informational purposes only and is not investment advice.

Read the original report